News

Akola Group to Enhance Poultry Operations with €13 Million Boost

Akola Group to Enhance Poultry Operations with €13 Million Boost

Akola Group's Strategic Investment for Poultry Growth

Akola Group is embarking on an ambitious €13 million investment program aimed at enhancing its poultry business, which includes notable brands in Lithuania and Latvia. This investment, scheduled for the upcoming financial year, emphasizes four major areas: advancing production technology, expanding incubation capabilities, reinforcing biosecurity measures, and improving environmental efficiency.

Modernization and Capacity Enhancements

In recent years, Akola Group has made consistent strides in updating its poultry operations. The company's Deputy Chairman, Andrius Pranckevi?ius, emphasized the importance of sustainability and operational reliability. In the past financial year alone, the poultry business generated impressive sales of €325 million, with an excellent gross profit of €69 million, reflecting the operational scale and enhanced efficiency. With over 120,000 tons of live-weight poultry produced, the group is positioned for substantial growth.

Advanced Production Technologies

The major projects currently underway at Vilniaus Paukštynas focus primarily on production modernization. The facility is adopting AI-driven technologies for meat preparation that will elevate production quality while ensuring compliance with safety regulations and animal welfare standards. The ongoing enhancements also include advanced odor control and air purification installations, alongside significant investments aimed at reducing environmental impact.

Strengthening Biosecurity Measures

In light of increasing avian disease outbreaks across Europe, the need for improved biosecurity has become a priority for Akola Group. Deputy CEO for Finance and Investments, Mažvydas Šileika, highlighted plans for around €9 million of investments dedicated to not only modernization but also to implementing robust environmental protection projects. These measures are essential in maintaining operational efficiency and safeguarding the supply chain against potential disruptions.

Positive Market Trends and Outcomes

As the new financial year unfolds, Akola Group reports stable poultry production levels, with no disease outbreaks, reflecting the effectiveness of their management strategies. Productivity is also high, particularly in Latvia, contributing to a fruitful market environment where stable prices have bolstered revenue performance. Recent data shows a significant revenue increase of 15%, alongside a gross profit surge of nearly 19% year-over-year.

Ongoing Commitment to Investment and Growth

In alignment with its growth strategy, Akola Group plans to allocate an impressive total of €43 million for various projects within the next financial year. This ambitious investment is aimed at ensuring that the group continues its upward trajectory, meeting growing consumer demands while enhancing operational capabilities.

A Look at Akola Group's Overall Performance

As the leading agribusiness and food production entity in the Baltics, employing over 5,000 people, Akola Group has a robust portfolio of companies operating throughout the complete food production chain. The previous financial year's figures further demonstrate the group's strength, with revenues of €1.58 billion and 3.1 million tons of products sold, highlighting their central role in the food industry.

Frequently Asked Questions

What is the primary focus of Akola Group's investment program?

The primary focus is on production modernization, capacity expansion, biosecurity measures, and improving environmental efficiency.

How much revenue did Akola Group generate in the last financial year?

In the 2024–2025 financial year, Akola Group generated €325 million in sales from its poultry business.

Where are Akola Group's poultry operations located?

The poultry operations are primarily based in Lithuania and Latvia, encompassing brands such as Vilniaus Paukštynas.

What technologies is Akola Group implementing in its poultry operations?

They are adopting AI-based carcass preparation technologies to enhance production quality and safety.

What overall investments are planned for Akola Group across the group in the financial year?

Akola Group plans to invest €43 million across various projects within the upcoming financial year.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Copper Peptides Shine in New Renue Blue Cream

Updated Category News Views 171

Renue By Science's Ambitious Skincare Launch Alright, we've got a big player stepping up in the realm of skincare with a new face cream packed tightly with science-backed goodies. Renue By Science is revamping their game by anchoring their new Renue Blue Face Cream around the star of the moment: copper tripeptide-1, also known as GHK-Cu. This is more than a beauty gloss...

Continue Reading
Alley Cat Allies Pushes for Humane Cat Conservation Bill

Updated Category News Views 70

Time to Rethink Conservation: Save the Cats If you’re tuned into the chatter buzzing around the Cayman Islands, you know the clocks are ticking for a decision that could change the approach to handling community cats. Alley Cat Allies is waving the flag, urging the Cayman Islands Parliament to pass a bill that abandons the archaic practice of culling cats by shooting...

Continue Reading
Cognito Unveils Phase 3 Results for Alzheimer Treatment

Updated Category News Views 292

Charting New Waters in Alzheimer's Treatment Well, here's one for the books, folks. Cognito Therapeutics just tossed their latest Phase 3 results from their so-called HOPE study into the ring. We're talking about Spectris AD, a non-drug, at-home gizmo that aims to be the next big thing for Alzheimer's. Yeah, the study didn't exactly hit a home run with the primary...

Continue Reading
Endava's Audit Scandal: Investors Face Crucial Decision

Updated Category News Views 156

Endava's Unexpected Crisis: What's Happening? It's the kind of mess no investor wants to wake up to: on October 28, 2026, Endava plc (NYSE: DAVA) laid out a smorgasbord of screw-ups that have left the market reeling. The company's last few days were a whirlwind, featuring the CFO's abrupt exit and the CEO swap. This shake-up didn't happen in isolation—the announcement...

Continue Reading
Peptide Tracker Refresh Unveils New Planning Features

Updated Category News Views 136

Peptide Tracker's Latest Updates: A Game Changer? I'll tell you what—if you're keeping tabs on your peptide intake like a seasoned gardener checks the soil, Peptide Tracker's fresh versions 3.2.0 and 3.3.0 might just be your new best mates. With the addition of washout scheduling and a robust six-month schedule preview, this isn't just another fancy tech update. It's...

Continue Reading
Kos & FORTH Partner to Spark Greek Biotech Growth

Updated Category News Views 81

New Frontiers: Greece on the Biotech Map Partnerships in biotech aren't tossed out willy-nilly; they're crafted for precision much like a sculptor shaping marble. Kos Biotechnology Partners and the Foundation for Research and Technology-Hellas (FORTH) are doing exactly that, teaming up to birth a biotechnology incubator on the FORTH campus in Heraklion, Crete. Now tell...

Continue Reading
Local Bounti Expands: Acquires CEA Facilities

Updated Category News Views 72

Local Bounti's Strategic Acquisition Move Local Bounti's at it again, shaking up the indoor agriculture scene by snapping up some real estate from Revol Greens. We're talking 30 acres of primo certified-organic greenhouse space across Texas and Minnesota. And they’re picking these babies up right as they’re ready to grow, not like some flashy land grab. Digging into...

Continue Reading
Quantum X and Everest Cloud Partner in South Asia Push

Updated Category News Views 108

An Unlikely Alliance for Cutting-Edge Tech You gotta admit, the fusion of a U.S.-based tech outfit with a Nepalese cloud provider wasn't the market move anyone saw coming. But here we are—Quantum X is hitching its quantum computing dreams to Everest Cloud's solid local foothold across six South Asian markets. We're talking Nepal, India, Bangladesh, Bhutan, Sri Lanka,...

Continue Reading
BWIN Acquisition Under Scrutiny: Shareholders Alerted

Updated Category News Views 118

BWIN Shareholders in the Hot Seat Over Acquisition Ever feel like you're the last one to know when the music stops in this investing dance? Well, if you're holding shares of The Baldwin Insurance Group, Inc. (NASDAQ:BWIN), it's time to put down your coffee and tune in. Levi & Korsinsky, LLP threw a wrench in the works, launching an investigation to see if this Sequence...

Continue Reading
Apotex Enters U.S. Market with Axitinib Tablets Launch

Updated Category News Views 114

Apotex's Bold Move: Axitinib Tablets Hit the U.S. Market Apotex is shaking things up in the pharma world by launching the first generic version of Axitinib Tablets in the U.S., aimed at treating advanced renal cell carcinoma (RCC) when previous treatments have fallen flat. This isn't just another dance with the red tape—it's a major step for Apotex, flexing their muscle...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring Natural Hydrogen: MAX Power Mining's Vision

Updated Category News Views 184

MAX Power Mining Corp. Driving Innovation in Natural Hydrogen In an era where energy demands are escalating, especially with the rise of artificial intelligence and advanced technologies, the search for sustainable power sources has reached new heights. Enter MAX Power Mining Corp. (OTC: MAXXF) (CSE: MAXX), a trailblazer in the natural hydrogen sector, demonstrating...

Continue Reading
Inland Empire Health Plan Achieves Excellence in GIS Recognition

Updated Category News Views 246

A Celebration of Achievement for Inland Empire Health Plan Inland Empire Health Plan (IEHP) has achieved remarkable recognition by winning its third Special Achievement in GIS (SAG) award from Esri, the global leader in Geographic Information System (GIS) technology. This prestigious accolade highlights IEHP's commitment to utilizing innovative technology to enhance...

Continue Reading
Ryp Labs Triumphs in Lineage’s Global Food Innovation Challenge

Updated Category News Views 226

Ryp Labs Triumphs in Lineage’s Global Food Innovation Challenge In a groundbreaking moment for sustainable food technology, Ryp Labs was announced as the standout winner of Lineage's prestigious innovation challenge aimed at transforming the global food supply chain. The challenge focused on innovative solutions that address pressing issues such as food waste and supply...

Continue Reading
Future Landscape of the UV Stabilizers Market by 2032

Updated Category News Views 176

Growth of the UV Stabilizers Market The UV stabilizers market is gaining momentum, projected to expand from USD 1.4 billion to USD 2.3 billion by 2032, with a compound annual growth rate (CAGR) of 5.5% during the 2024-2032 period. This growth is fueled by the increasing demand for materials that are durable and can endure the degrading effects of ultraviolet (UV)...

Continue Reading
Dr. Rushika Fernandopulle Joins Premera Board of Directors

Updated Category News Views 337

Dr. Rushika Fernandopulle Joins Premera's Board Premera Blue Cross is excited to announce the addition of Dr. Rushika Fernandopulle to its Board of Directors. This decision is part of a strategic effort to strengthen leadership and expertise within the organization. Dr. Fernandopulle takes over from Dr. John Jenrette, who has completed his term this year. Expertise and...

Continue Reading